Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study

[1]  M. Dalla Vestra,et al.  Myasthenia Gravis following Low-Osmolality Iodinated Contrast Media , 2014, Case reports in radiology.

[2]  R. Pascuzzi,et al.  Complications of radiologic contrast in patients with myasthenia gravis , 2014, Muscle & nerve.

[3]  J. Ellis,et al.  Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis. , 2013, Radiology.

[4]  F. Zimprich,et al.  Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society , 2012, Wiener klinische Wochenschrift.

[5]  E. Williamson,et al.  Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist. , 2012, Mayo Clinic proceedings.

[6]  R. Pascuzzi,et al.  Medications and Myasthenia Gravis ( A Reference for Health Care Professionals ) , 2012 .

[7]  Chin-Shang Li,et al.  Delayed adverse reaction to contrast-enhanced CT: a prospective single-center study comparison to control group without enhancement. , 2010, Radiology.

[8]  G. Anzola,et al.  Myasthenic crisis during intravenous iodinated contrast medium injection , 1986, The Italian Journal of Neurological Sciences.

[9]  L. Bacheschi,et al.  Exacerbation of myasthenia gravis by contrast media. , 1994, AJR. American journal of roentgenology.

[10]  I. Wirguin,et al.  Aggravation of human and experimental myasthenia gravis by contrast media , 1990, Neurology.

[11]  T. Kozuka,et al.  Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. , 1990, Radiology.

[12]  W. Black,et al.  Iodinated contrast agents in myasthenia gravis , 1987, Neurology.

[13]  J. Leroy,et al.  Myasthenic crisis following the injection of an iodinated contrast medium. , 1987, Intensive care medicine.

[14]  Y. Goldhammer,et al.  Myasthenic crisis after intraxenous administration of iodinated contrast agent , 1985, Neurology.

[15]  M. Franceschi,et al.  MYASTHENIC CRISIS PRECIPITATED BY IOTHALAMIC ACID , 1983, The Lancet.

[16]  J. Polak,et al.  Letter: Antral-gastrin-cell hyperplasia in peptic-ulcer disease. , 1974, Lancet.